A Randomized, Controlled Multisite Study of Behavioral Interventions for Veterans with Mental Illness and Antipsychotic Medication-Associated Obesity
- PMID: 28271424
- PMCID: PMC5359155
- DOI: 10.1007/s11606-016-3960-3
A Randomized, Controlled Multisite Study of Behavioral Interventions for Veterans with Mental Illness and Antipsychotic Medication-Associated Obesity
Abstract
Background: Weight gain and other metabolic sequelae of antipsychotic medications can lead to medication non-adherence, reduced quality of life, increased costs, and premature mortality. Of the approaches to address this, behavioral interventions are less invasive, cost less, and can result in sustained long-term benefits.
Objective: We investigated behavioral weight management interventions for veterans with mental illness across four medical centers within the Veterans Affairs (VA) Healthcare System.
Design: We conducted a 12-month, multi-site extension of our previous randomized, controlled study, comparing treatment and control groups.
Participants: Veterans (and some non-veteran women) diagnosed with mental illness, overweight (defined as having a BMI over 25), and required ongoing antipsychotic therapy.
Interventions: One group received "Lifestyle Balance" (LB; modified from the Diabetes Prevention Program) consisting of classes and individual nutritional counseling with a dietitian. A second group received less intensive "Usual Care" (UC) consisting of weight monitoring and provision of self-help.
Main measures: Participants completed anthropometric and nutrition assessments weekly for 8 weeks, then monthly. Psychiatric, behavioral, and physical assessments were conducted at baseline and months 2, 6, and 12. Metabolic and lipid laboratory tests were performed quarterly.
Key results: Participants in both groups lost weight. LB participants had a greater decrease in average waist circumference [F(1,1244) = 11.9, p < 0.001] and percent body fat [F(1,1121) = 4.3, p = 0.038]. Controlling for gender yielded statistically significant changes between groups in BMI [F(1,1246) = 13.9, p < 0.001]. Waist circumference and percent body fat decreased for LB women [F(1,1243) = 22.5, p < 0.001 and F(1,1221) = 4.8, p = 0.029, respectively]. The majority of LB participants kept food and activity journals (92%), and average daily calorie intake decreased from 2055 to 1650 during the study (p < 0.001).
Conclusions: Behavioral interventions specifically designed for individuals with mental illness can be effective for weight loss and improve dietary behaviors. "Lifestyle Balance" integrates well with VA healthcare's patient-centered "Whole Health" approach. ClinicalTrials.gov identifier NCT01052714.
Keywords: antipsychotic; behavioral intervention; mental health; obesity; weight management.
Conflict of interest statement
Dr. Charles Nguyen owns stock in Orexigen Therapeutics, Inc., has received research grants from Forest Laboratory, Inc., and is a consultant and part of the Speakers Bureaus for Eisai Co., Ltd., and Otsuka America Pharmaceutical, Inc. All other authors declare no conflicts of interest.
Similar articles
-
Behavioral interventions for antipsychotic medication-associated obesity: a randomized, controlled clinical trial.J Clin Psychiatry. 2016 Feb;77(2):e183-9. doi: 10.4088/JCP.14m09552. J Clin Psychiatry. 2016. PMID: 26930534 Clinical Trial.
-
Improving Weight in People with Serious Mental Illness: The Effectiveness of Computerized Services with Peer Coaches.J Gen Intern Med. 2017 Apr;32(Suppl 1):48-55. doi: 10.1007/s11606-016-3963-0. J Gen Intern Med. 2017. PMID: 28271427 Free PMC article. Clinical Trial.
-
Behavioral treatment of obesity in patients taking antipsychotic medications.J Clin Psychiatry. 2005 Aug;66(8):1058-63. doi: 10.4088/jcp.v66n0815. J Clin Psychiatry. 2005. PMID: 16086623 Clinical Trial.
-
Lifestyle Interventions for Weight Management in People with Serious Mental Illness: A Systematic Review with Meta-Analysis, Trial Sequential Analysis, and Meta-Regression Analysis Exploring the Mediators and Moderators of Treatment Effects.Psychother Psychosom. 2019;88(6):350-362. doi: 10.1159/000502293. Epub 2019 Sep 13. Psychother Psychosom. 2019. PMID: 31522170
-
Effectiveness of lifestyle intervention on prevention/management of antipsychotic-induced weight gain among persons with severe mental illness: A systematic review and meta-analysis.J Health Psychol. 2024 Jun;29(7):690-706. doi: 10.1177/13591053241227384. Epub 2024 Jan 22. J Health Psychol. 2024. PMID: 38251661
Cited by
-
Systematic review of lifestyle interventions to improve weight, physical activity and diet among people with a mental health condition.Syst Rev. 2022 Sep 9;11(1):198. doi: 10.1186/s13643-022-02067-3. Syst Rev. 2022. PMID: 36085250 Free PMC article.
-
Outcomes and safety of concomitant topiramate or metformin for antipsychotics-induced obesity: a randomized-controlled trial.Ann Gen Psychiatry. 2020 Dec 10;19(1):68. doi: 10.1186/s12991-020-00319-x. Ann Gen Psychiatry. 2020. PMID: 33302986 Free PMC article.
-
The impact of participant mental health on attendance and engagement in a trial of behavioural weight management programmes: secondary analysis of the WRAP randomised controlled trial.Int J Behav Nutr Phys Act. 2021 Nov 7;18(1):146. doi: 10.1186/s12966-021-01216-6. Int J Behav Nutr Phys Act. 2021. PMID: 34743721 Free PMC article. Clinical Trial.
-
Effectiveness of nutrition and dietary interventions for people with serious mental illness: systematic review and meta-analysis.Med J Aust. 2022 Oct 2;217 Suppl 7(Suppl 7):S7-S21. doi: 10.5694/mja2.51680. Med J Aust. 2022. PMID: 36183316 Free PMC article.
-
Therapeutic patient education for severe mental disorders: A systematic review.Glob Ment Health (Camb). 2024 Oct 10;11:e78. doi: 10.1017/gmh.2024.68. eCollection 2024. Glob Ment Health (Camb). 2024. PMID: 39464569 Free PMC article. Review.
References
-
- Das C, Mendez G, Jagasia S, Labbate LA. Second-generation antipsychotic use in schizophrenia and associated weight gain: a critical review and meta-analysis of behavioral and pharmacologic treatments. Ann Clin Psychiatry. 2012;24(3):225–239. - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical